Ảnh hưởng của lựa chọn thuốc chống trầm cảm đến tỷ lệ nhập viện và mức độ chi phí điều trị nội trú ở những người bị trầm cảm
Tóm tắt
Từ khóa
#thuốc chống trầm cảm #trầm cảm #nhập viện #chi phí điều trị nội trú #SSRIs #TCAsTài liệu tham khảo
Croghan,T.W., Lair,T.J., Engelhart,L., Crown,W.E., Copley-Merriman,C., Melfi,C.A., Obenchain,R.L., & Buesching,D.P.(1997).Effect of antidepressant therapy of health care utilization and costs in primary care.Psychiatric Services,48,1420–1426.
Crown,W.E., Obenchain,R.L., Engelhart,L., Lair,T.J., Buesching,D.P., & Croghan,T.W.(1998). The application of sample selection models in evaluating treatment effects:The case for examining the effects of antidepressant medication.Statistics in Medicine 17,1943–1958.
Fetter,R.B., Brand,D.A., & Gamache,D.(Eds.).(1991).DRGs:Their design and development.Ann Arbor,MI: Health Administration Press.
Greenberg,P., Stiglin,L.E., Finklestein,S., & Berndt,E.R.(1993).The economic burden of depression in 1990.Journal of Clinical Psychiatry,54,405–418.
Greene,W.H.(1995).LIMDEP,version 7.New York,NY: Econometric Software,Inc.
Greene,W.H.(1997).Econometric analysis(3rd ed.).(1997).Upper Saddle River,NJ: Prentice-Hall,Inc.
Hays,R.D., Wells,K.B., Sherbourne,C.D., & Spritzer,K.(1995).Functional well-being outcomes of patients with depression compared with chronic medical illnesses.Archives of General Psychiatry,52,11–19.
Hotopf,M., Lewis,G., & Normand,C.(1996).Are SSRIs a cost-effective alternative to tricyclics?British Journal of Psychiatry,168,404–409.
Hylan,T.R., Crown,W.E., Meneades,L., Heiligenstein,J.H., Melfi,C.A., Croghan,T.W., & Buesching, D.P.(1998).TCA and SSRI antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis.Journal of Affective Disorders,47,71–79.
Hylan,T.R., Crown,W.E., Meneades,L., Heilegenstein,J.H., Melfi,C.A., Croghan,T.W., & Buesching, D.P.(1999).Tricyclic and SSRI antidepressant use patterns in the naturalistic setting:A multivariate analysis.Medical Care,37 (4),AS24–31.
Johnson,C.A.(1987).Readmission to the mental hospital:An indicator of quality of care?Journal of Mental Health Administration,14,51–55.
Johnson,J., Weissman,M., & Klerman,G.L.(1992).Service utilization and social morbidity associated with depressive symptoms in the community.Journal of the American Medical Association 267,1478–1483.
Kessler,R.C., McGonagle,K.A., Zhao,S., Nelson,C.B., Highes,M., Eshleman,S., Wittchen,H.U., & Kendler,K.S.(1994).Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States:Results from the National Comorbidity Survey.Archives of General Psychiatry,51,9–19.
Klinkenberg,W.D., & Calsyn,R.J.(1996).Predictors of receipt of aftercare and recidivism among persons with severe mental illness:A review.Psychiatric Services,47,487–496.
Klinkenberg,W.D., & Calsyn,R.J.(1998).Predictors of mental health hospitalization:A multivariate analysis.Administration and Policy in Mental Health,25,403–410.
Levenson,J., Hamer,R.M., & Rossiter,L.F.(1990).Relation of psychopathology in general medical inpatients to use and cost of services.American Journal of Psychiatry,147,1498–1503.
Manning,W., & Wells,K.B.(1992).The effects of psychological distress and psychological well-being on use of medical services.Medical Care,30,541–553.
Melfi,C.A., Chawla,A., Croghan,T.W., Hanna,M.P., Kennedy,S., & Sredl,K.(1998).Effect of adher-ence to guidelines to antidepressant treatment on relapse and recurrence of depression.Archives of General Psychiatry,55,1128–1132.
Potter,W.Z., Rudorfer,M.V., & Monji,H.(1991).The pharmacologic treatment of depression.New England Journal of Medicine,325,633–642.
Regier,D.A., Boyd,J.H., Burke,J.D., Rae,D.S., Myers,J.K., Kramer,M., Robins,L.N., George,L.K., Karno,M., & Locke,B.Z.(1986).One-month prevalence of mental disorders in the United States. Archives of General Psychiatry,45,977–986.
Reimherr,F.W., Amsterdam,J.D., Quitkin,F.M., Rosenbaum,J.F., Fava,M., Zajecka,J., Beasley,Jr., C.M., Michelson,D., Roback,P., & Sundell,K.(1998).Optimal length of continuation therapy in depression:A prospective assessment during long-term fluoxetine treatment.American Journal of Psychiatry,155,1247–1253.
Rosenbaum,J.F., Fava,M., Hoog,S.L., Ascroft,R.C., & Krebs,W.B.(1998).Selective serotonin reup-take inhibitor discontinuation syndrome:A randomized clinical trial.Biological Psychiatry,44(2),77–87.
Rudorfer,M.V., Manji,H.K., & Potter,W.Z.(1994).Comparative tolerability profiles of the newer versus older antidepressants.Drug Safety,10,1846.
Sclar,D.A., Robison,L.M., Skaer,T.L., Galin,R.S., Legg,R.G., Nemec,N.L., Hughes,T.E., Buesching, D.P., & Morgan,M.(1995).Antidepressant pharmacotherapy:Economic evaluation of fluoxetine, paroxetine,and sertraline in a health maintenance organization.Journal of International Medical Re-search,23,365–412.
Sclar,D.A., Robison,L.M., Skaer,T.L., Legg,R.F., Nemec,N.L., Galin,R.S., Highes,T.E., & Buesch-ing,D.P.(1994).Antidepressant pharmacotherapy:economic outcomes in a health maintenance organization.Clinical Therapeutics,16,715–730.
Simon,G., Ormel,J., VonKorff,M., & Barlow,W.(1995).Health care costs associated with depressive and anxiety disorders in primary care.American Journal of Psychiatry,152,352–357.
Simon,G.E., VonKorff,M., Heiligenstein,J.H., Revicki,D.A., Grothaus,L., Katon,W., & Wagner,E.H. (1996).Initial antidepressant choice in primary care:Economic outcomes in a health maintenance organization.Journal of the American Medical Association,275,1897–1902.
Skaer,T.L., Sclar,D.A., Robison,L.M., Galin,R.S., Legg,R.F., & Nemec,N.L.(1994).Economic evalu-ation of amitriptyline,desipramine,nortriptyline,and sertraline in the management of patients with depression.Current Therapeutic Research,56,556–567.
VonKorff,M., Ormel,J., Katon,W., & Lin,E.(1992).Disability and depression among high utilizers of health care:A longitudinal analysis.Archives of General Psychiatry,49,91–100.